0001567619-19-022828.txt : 20191210
0001567619-19-022828.hdr.sgml : 20191210
20191210161951
ACCESSION NUMBER: 0001567619-19-022828
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191206
FILED AS OF DATE: 20191210
DATE AS OF CHANGE: 20191210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Adams Gabrielle B.
CENTRAL INDEX KEY: 0001651089
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10670
FILM NUMBER: 191277908
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE, SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HANGER, INC.
CENTRAL INDEX KEY: 0000722723
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 840904275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
BUSINESS PHONE: 512-777-3800
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
FORMER COMPANY:
FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUEL CORP
DATE OF NAME CHANGE: 19890814
FORMER COMPANY:
FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC
DATE OF NAME CHANGE: 19860304
4
1
doc1.xml
FORM 4
X0306
4
2019-12-06
0
0000722723
HANGER, INC.
HGR
0001651089
Adams Gabrielle B.
10910 DOMAIN DRIVE, SUITE 300
AUSTIN
TX
78758
0
1
0
0
Vice President Accounting
Common Stock
2019-12-06
4
M
0
10000
12.77
A
49580
D
Common Stock
2019-12-06
4
S
0
10000
26.8129
D
39580
D
Stock Options (right to buy)
12.77
2019-12-06
4
M
0
10000
0
D
2027-05-19
Common Stock
10000
20938
D
Performance Share Units
2020-05-19
Common Stock
12375
12375
D
The price in Column 4 is a weighted average price. The prices actually received ranged from $26.77 to $26.88. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.
Includes (i) unvested restricted shares totaling 4,567 shares of stock from an initial grant of 4,567 shares of restricted stock that begins to vest on March 8, 2020; (ii) unvested restricted shares and fully vested shares totaling 4,054 shares of stock from an initial grant of 4,435 shares of restricted stock made on March 9, 2018; (iii) unvested restricted shares and fully vested shares totaling 5,095 shares of stock from an initial grant of 5,574 shares of restricted stock made on March 9, 2018; (iv) unvested restricted shares and fully vested shares totaling 7,266 shares of stock from an initial grant of 7,950 shares of restricted stock made on March 8, 2017;[continued in next footnote]
(v) unvested restricted shares and fully vested shares totaling 2,742 shares of stock from an initial grant of 3,000 shares of restricted stock made on October 11, 2016; (vi) unvested restricted shares and fully vested shares totaling 6,981 shares of stock from an initial grant of 7,750 shares of restricted stock made on April 29, 2016; (vii) fully vested shares which total 3,020 shares of stock from an initial grant of 3,305 shares of restricted stock made on November 10, 2015; [continued in next footnote]
(viii) fully vested shares which total 2,037 shares of stock from an initial grant of 2,229 shares of restricted stock made on September 8, 2015; and (ix) fully vested shares which total 3,818 shares of stock from an initial grant of 4,239 shares of restricted stock made on March 6, 2015.
Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020.
Performance share units ("PSUs") were granted under the Company's Special Equity Plan. Each PSU represents a contingent right to receive one share of common stock if predetermined levels of absolute common stock price compounded annual growth rate are achieved over a three-year performance period ending on the third anniversary of the grant date. The number of PSUs shown in the table represents the maximum number that could be earned; the target number is one-half the maximum number.
Jessica Lochmann Allen, Attorney-in-Fact for Gabrielle B. Adams
2019-12-09